Dr. Peter Schmid
Company: Barts Cancer Institute
Job title: Professor of Cancer Medicine
Seminars:
Immuno-Oncology in Triple Negative Breast Cancer & Future Perspectives for Other Subtypes 7:10 pm
day: Clinical Implications of Novel Immuno-Oncology Biomarkers
Panel Discussion: Precision Medicine Beyond Targeted Therapy: an EU Perspective 7:30 pm
Addressing the different challenges and advantages of novel liquid diagnostic approaches Discussing large opportunities in the Immuno-Oncology field when it comes to developing drugs with high efficacy in both early and late-stage cancer Unravelling the necessary steps to take a diagnostic tool all the way through to companion diagnostic approvalRead more
day: Clinical Implications of Novel Immuno-Oncology Biomarkers